atc_level_01_code,atc_level_01_name,atc_level_02_code,atc_level_02_name,atc_level_03_code,atc_level_03_name,atc_level_04_code,atc_level_04_name,atc_level_04_note,atc_level_05_code,atc_level_05_name,DDD_O,DDD_P,DDD_R,DDD_SL,DDD_TD,note,unit_O,unit_P,unit_R,unit_SL,unit_TD
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA01,sodium fluoride,1.1,NA,NA,NA,NA,0.5 mg fluoride,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA02,sodium monofluorophosphate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA03,olaflur,1.1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA04,stannous fluoride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA30,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,"For caries prophylactic agents in A01AA, the DDDs are based on use in children.  DDDs are only established for tablets.",A01AA51,"sodium fluoride, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB02,hydrogen peroxide,60,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB03,chlorhexidine,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB04,amphotericin B,40,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB05,polynoxylin,0.18,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB06,domiphen,3,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB07,oxyquinoline,80,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB08,neomycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB09,miconazole,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB10,natamycin,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB11,various,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB12,hexetidine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB13,tetracycline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB14,benzoxonium chloride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB15,tibezonium iodide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB16,mepartricin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB17,metronidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB18,clotrimazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB19,sodium perborate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB21,chlortetracycline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB22,doxycycline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB23,minocycline,1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB24,octenidine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB25,oxytetracycline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.,A01AB53,chlorhexidine and cetylpyridinium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,No DDDs have been established in this group.  The dosage forms are mainly ointments and pastes.,A01AC01,triamcinolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,No DDDs have been established in this group.  The dosage forms are mainly ointments and pastes.,A01AC02,dexamethasone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,No DDDs have been established in this group.  The dosage forms are mainly ointments and pastes.,A01AC03,hydrocortisone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,No DDDs have been established in this group.  The dosage forms are mainly ointments and pastes.,A01AC04,prednisolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,No DDDs have been established in this group.  The dosage forms are mainly ointments and pastes.,A01AC54,"prednisolone, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD01,epinephrine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD02,benzydamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD05,acetylsalicylic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD06,adrenalone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD07,amlexanox,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD08,becaplermin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment,NA,A01AD11,various,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA01,magnesium carbonate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA02,magnesium oxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA03,magnesium peroxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA04,magnesium hydroxide,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA05,magnesium silicate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,Magnesium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AA10,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB01,aluminium hydroxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB02,algeldrate,5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB03,aluminium phosphate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB04,dihydroxialumini sodium carbonate,4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB05,aluminium acetoacetate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB06,aloglutamol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB07,aluminium glycinate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,Aluminium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AB10,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AC,Calcium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AC01,calcium carbonate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AC,Calcium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AC02,calcium silicate,6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AC,Calcium compounds,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AC10,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds","The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AD01,ordinary salt combinations,NA,NA,NA,NA,NA,Standard dose: 10 tablets or 50 ml mixt,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds","The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AD02,magaldrate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds","The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AD03,almagate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds","The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AD04,hydrotalcite,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds","The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AD05,almasilate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AF,Antacids with antiflatulents,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AF01,magaldrate and antiflatulents,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AF,Antacids with antiflatulents,"The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus.  One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).",A02AF02,ordinary salt combinations and antiflatulents,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AG,Antacids with antispasmodics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AH,Antacids with sodium bicarbonate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AX,"Antacids, other combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA01,cimetidine,0.8,0.8,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA02,ranitidine,0.3,0.3,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA03,famotidine,40,40,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA04,nizatidine,0.3,0.3,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA05,niperotidine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA06,roxatidine,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA07,ranitidine bismuth citrate,0.8,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA08,lafutidine,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA51,"cimetidine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,The DDDs are based on treatment of peptic ulcers.,A02BA53,"famotidine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BB,Prostaglandins,NA,A02BB01,misoprostol,0.8,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BB,Prostaglandins,NA,A02BB02,enprostil,70,NA,NA,NA,NA,NA,mcg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC01,omeprazole,20,20,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC02,pantoprazole,40,40,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC03,lansoprazole,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC04,rabeprazole,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC05,esomeprazole,30,30,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC06,dexlansoprazole,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC07,dexrabeprazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC08,vonoprazan,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC09,tegoprazan,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC51,"omeprazole, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC53,"lansoprazole, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors,The DDDs are based on treatment of gastro-oesophageal reflux disease.,A02BC54,"rabeprazole, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD01,"omeprazole, amoxicillin and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD02,"lansoprazole, tetracycline and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD03,"lansoprazole, amoxicillin and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD04,"pantoprazole, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD05,"omeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD06,"esomeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD07,"lansoprazole, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD08,"bismuth subcitrate, tetracycline and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD09,"lansoprazole, clarithromycin and tinidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD10,"lansoprazole, amoxicillin and levofloxacin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD11,"pantoprazole, amoxicillin, clarithromycin and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD12,"rabeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD13,"rabeprazole, amoxicillin and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD14,"vonoprazan, amoxicillin and clarithromycin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD15,"vonoprazan, amoxicillin and metronidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD16,"omeprazole, amoxicillin and rifabutin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BD,Combinations for eradication of Helicobacter pylori,"The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD.",A02BD17,vonoprazan and amoxicillin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX01,carbenoxolone,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX02,sucralfate,4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX03,pirenzepine,0.1,20,NA,NA,NA,NA,g,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX04,methiosulfonium chloride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX05,bismuth subcitrate,0.48,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX06,proglumide,1.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX07,gefarnate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX08,sulglicotide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX09,acetoxolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX10,zolimidine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX11,troxipide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX12,bismuth subnitrate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX13,alginic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX14,rebamipide,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX15,teprenone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX16,irsogladine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX51,"carbenoxolone, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX71,"carbenoxolone, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD).,A02BX77,"gefarnate, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A02,DRUGS FOR ACID RELATED DISORDERS,A02X,OTHER DRUGS FOR ACID RELATED DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA01,oxyphencyclimine,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA03,camylofin,0.2,NA,0.2,NA,NA,NA,g,NA,g,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA04,mebeverine,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA05,trimebutine,0.6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA06,rociverine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA07,dicycloverine,80,80,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA08,dihexyverine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA09,difemerine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AA30,piperidolate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB01,benzilone,70,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB02,glycopyrronium bromide,3,0.3,3,NA,NA,NA,mg,mg,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB03,oxyphenonium,25,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB04,penthienate,15,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB05,propantheline,60,60,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB06,otilonium bromide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB07,methantheline,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB08,tridihexethyl,0.125,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB09,isopropamide,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB10,hexocyclium,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB11,poldine,12,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB12,mepenzolate,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB13,bevonium,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB14,pipenzolate,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB15,diphemanil,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB16,(2-benzhydryloxyethyl)diethyl-methylammonium iodide,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB17,tiemonium iodide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB18,prifinium bromide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB19,timepidium bromide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB21,fenpiverinium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose. The parenteral DDD for glycopyrronium bromide is based on the use as premedication for anesthetic procedures.",A03AB53,"oxyphenonium, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AC,"Synthetic antispasmodics, amides with tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AC02,dimethylaminopropionylphenothiazine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AC,"Synthetic antispasmodics, amides with tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AC04,nicofetamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AC,"Synthetic antispasmodics, amides with tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AC05,tiropramide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AD,Papaverine and derivatives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AD01,papaverine,0.1,0.1,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AD,Papaverine and derivatives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AD02,drotaverine,0.1,0.1,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AD,Papaverine and derivatives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AD30,moxaverine,50,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AE,Serotonin receptor antagonists,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AE01,alosetron,1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AE,Serotonin receptor antagonists,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AE03,cilansetron,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX01,fenpiprane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX02,diisopromine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX03,chlorbenzoxamine,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX04,pinaverium,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX05,fenoverine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX06,idanpramine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX07,proxazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX08,alverine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX09,trepibutone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX10,isometheptene,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX11,caroverine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX12,phloroglucinol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX13,silicones,0.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX14,valethamate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX15,menthae piperitae aetheroleum,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX30,trimethyldiphenylpropylamine,50,50,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03AX58,"alverine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BA,"Belladonna alkaloids, tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BA01,atropine,1.5,1.5,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BA,"Belladonna alkaloids, tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BA03,hyoscyamine,1.2,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BA,"Belladonna alkaloids, tertiary amines","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BA04,belladonna total alkaloids,1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB01,butylscopolamine,60,60,60,NA,NA,NA,mg,mg,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB02,methylatropine,3,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB03,methylscopolamine,12,12,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB04,fentonium,60,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB05,cimetropium bromide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES, PLAIN",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds","The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03BB06,homatropine methylbromide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA01,isopropamide and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA02,clidinium and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA03,oxyphencyclimine and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA04,otilonium bromide and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA05,glycopyrronium bromide and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA06,bevonium and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA07,ambutonium and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA08,diphemanil and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA09,pipenzolate and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA30,emepronium and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CA,Synthetic anticholinergic agents in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CA34,propantheline and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CB,Belladonna and derivatives in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CB01,methylscopolamine and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CB,Belladonna and derivatives in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CB02,belladonna total alkaloids and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CB,Belladonna and derivatives in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CB03,atropine and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CB,Belladonna and derivatives in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CB04,homatropine methylbromide and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CB,Belladonna and derivatives in combination with psycholeptics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03CB31,hyoscyamine and psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,A03CC,Other antispasmodics in combination with psycholeptics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA01,tropenzilone and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA02,pitofenone and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA03,bevonium and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA04,ciclonium and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA05,camylofin and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA06,trospium and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DA,Synthetic anticholinergic agents in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DA07,tiemonium iodide and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DB,Belladonna and derivatives in combination with analgesics,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03DB04,butylscopolamine and analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,A03DC,Other antispasmodics in combination with analgesics,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03E,ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS,A03EA,"Antispasmodics, psycholeptics and analgesics in combination",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03E,ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS,A03ED,Antispasmodics in combination with other drugs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA01,metoclopramide,30,30,30,NA,NA,NA,mg,mg,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA02,cisapride,30,NA,30,NA,NA,NA,mg,NA,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA03,domperidone,30,30,0.12,NA,NA,NA,mg,mg,g,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA04,bromopride,20,20,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA05,alizapride,0.15,0.15,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA06,clebopride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA07,itopride,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA08,cinitapride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA09,mosapride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,"The DDD for the substances is usually equal for different routes of administration (oral, parenteral or rectal) of the same compound and is based on the oral dose.",A03FA10,acotiamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA01,ondansetron,16,16,16,NA,NA,NA,mg,mg,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA02,granisetron,2,3,NA,NA,3.1,NA,mg,mg,NA,NA,mg
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA03,tropisetron,5,5,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA04,dolasetron,0.2,0.1,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA05,palonosetron,0.5,0.25,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,The DDDs are based on antiemetic treatment. The DDD for palonosetron is based on single dose treatment.,A04AA55,"palonosetron, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD01,scopolamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD02,cerium oxalate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD04,chlorobutanol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD05,metopimazine,15,15,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD10,dronabinol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD11,nabilone,3,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD12,aprepitant,NA,150,NA,NA,NA,Refers to fosaprepitant,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD12,aprepitant,165,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD13,casopitant,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD14,rolapitant,0.18,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD51,"scopolamine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics,The DDD for scopolamine plaster is one plaster (i.e. 1 UD).  This DDD is based on prophylaxis of motion sickness.DDDs for other substances classified in this group are based on antiemetic treatment.The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.,A04AD54,"chlorobutanol, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AA,Bile acids and derivatives,NA,A05AA01,chenodeoxycholic acid,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AA,Bile acids and derivatives,NA,A05AA02,ursodeoxycholic acid,0.75,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AA,Bile acids and derivatives,NA,A05AA03,cholic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AA,Bile acids and derivatives,NA,A05AA04,obeticholic acid,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AA,Bile acids and derivatives,NA,A05AA05,ursodoxicoltaurine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AB,Preparations for biliary tract therapy,NA,A05AB01,nicotinyl methylamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX01,piprozolin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX02,hymecromone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX03,cyclobutyrol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX04,maralixibat chloride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX05,odevixibat,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05A,BILE THERAPY,A05AX,Other drugs for bile therapy,NA,A05AX06,elafibranor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA01,arginine glutamate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA03,silymarin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA04,citiolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA05,epomediol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA06,ornithine oxoglurate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA07,tidiacic arginine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA08,glycyrrhizic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA09,metadoxine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy,NA,A05BA10,phospholipids,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A05,BILE AND LIVER THERAPY,A05C,DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AA,"Softeners, emollients","DDDs for e.g. liquid paraffin and castor oil are given using the following unit: g (gram), (1 g = 1 ml for all practical purposes). Preparations classified in A06AA51 - liquid paraffin, combinations, are all given the same DDD = 3 UD (15 ml), independent of liquid paraffin concentration.",A06AA01,liquid paraffin,15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AA,"Softeners, emollients","DDDs for e.g. liquid paraffin and castor oil are given using the following unit: g (gram), (1 g = 1 ml for all practical purposes). Preparations classified in A06AA51 - liquid paraffin, combinations, are all given the same DDD = 3 UD (15 ml), independent of liquid paraffin concentration.",A06AA02,docusate sodium,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AA,"Softeners, emollients","DDDs for e.g. liquid paraffin and castor oil are given using the following unit: g (gram), (1 g = 1 ml for all practical purposes). Preparations classified in A06AA51 - liquid paraffin, combinations, are all given the same DDD = 3 UD (15 ml), independent of liquid paraffin concentration.",A06AA51,"liquid paraffin, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB01,oxyphenisatine,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB02,bisacodyl,10,NA,10,NA,NA,NA,mg,NA,mg,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB03,dantron,50,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB04,phenolphthalein,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB05,castor oil,20,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB06,senna glycosides,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB07,cascara,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB08,sodium picosulfate,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB09,bisoxatin,0.12,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB20,contact laxatives in combination,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB30,contact laxatives in combination with belladonna alkaloids,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB52,"bisacodyl, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB53,"dantron, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB56,"senna glycosides, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB57,"cascara, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,NA,A06AB58,"sodium picosulfate, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC01,ispaghula (psylla seeds),7,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC02,ethulose,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC03,sterculia,8,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC05,linseed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC06,methylcellulose,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC07,triticum (wheat fibre),10,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC08,polycarbophil calcium,2.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC51,"ispaghula, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC53,"sterculia, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,NA,A06AC55,"linseed, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD01,magnesium carbonate,7,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD02,magnesium oxide,7,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD03,magnesium peroxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD04,magnesium sulfate,7,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD10,mineral salts in combination,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD11,lactulose,6.7,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD12,lactitol,10,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD13,sodium sulfate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD14,pentaerithrityl,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD15,macrogol,10,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD16,mannitol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD17,sodium phosphate,50,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD18,sorbitol,10,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD19,magnesium citrate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD21,sodium tartrate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD61,"lactulose, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,The DDD for macrogol refers to macrogol 4000.,A06AD65,"macrogol, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG01,sodium phosphate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG02,bisacodyl,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG03,"dantron, incl. combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG04,glycerol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG06,oil,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG07,sorbitol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG10,"docusate sodium, incl. combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG11,"sodium lauryl sulfoacetate, incl. combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enemas,The DDDs for enemas classified in this group are 1 enema.,A06AG20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,NA,A06AH01,methylnaltrexone bromide,NA,6,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,NA,A06AH02,alvimopan,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,NA,A06AH03,naloxegol,25,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,NA,A06AH04,naloxone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,NA,A06AH05,naldemedine,0.2,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX01,glycerol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX02,carbon dioxide producing drugs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX03,lubiprostone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX04,linaclotide,0.29,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX05,prucalopride,2,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX06,tegaserod,12,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX07,plecanatide,3,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX08,tenapanor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation,The DDD for linaclotide is based on treatment of irritable bowel syndrome with constipation.,A06AX09,elobixibat,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA01,neomycin,5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA02,nystatin,1.5,NA,NA,NA,NA,NA,MU,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA03,natamycin,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA04,streptomycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA05,polymyxin B,3,NA,NA,NA,NA,NA,MU,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA06,paromomycin,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA07,amphotericin B,0.4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA08,kanamycin,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA09,vancomycin,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA10,colistin,9,NA,NA,NA,NA,NA,MU,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA11,rifaximin,0.6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA12,fidaxomicin,0.4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA13,rifamycin,0.8,NA,NA,NA,NA,as sodium salt,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA51,"neomycin, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,Antibiotics,The DDDs are based on treatment of intestinal infections.,A07AA54,"streptomycin, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AB,Sulfonamides,The DDDs are based on preoperative prophylaxis of intestinal infections.,A07AB02,phthalylsulfathiazole,9,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AB,Sulfonamides,The DDDs are based on preoperative prophylaxis of intestinal infections.,A07AB03,sulfaguanidine,4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AB,Sulfonamides,The DDDs are based on preoperative prophylaxis of intestinal infections.,A07AB04,succinylsulfathiazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AC,Imidazole derivatives,The DDDs are based on treatment of gastrointestinal mycosis.,A07AC01,miconazole,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AX,Other intestinal antiinfectives,NA,A07AX01,broxyquinoline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AX,Other intestinal antiinfectives,NA,A07AX02,acetarsol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AX,Other intestinal antiinfectives,NA,A07AX03,nifuroxazide,0.6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AX,Other intestinal antiinfectives,NA,A07AX04,nifurzide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BA,Charcoal preparations,The DDD for charcoal preparations is based on treatment of common diarrhea.,A07BA01,medicinal charcoal,5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BA,Charcoal preparations,The DDD for charcoal preparations is based on treatment of common diarrhea.,A07BA51,"medicinal charcoal, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BB,Bismuth preparations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC01,pectin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC02,kaolin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC03,crospovidone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC04,attapulgite,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC05,diosmectite,9,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC30,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents,NA,A07BC54,"attapulgite, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07C,ELECTROLYTES WITH CARBOHYDRATES,A07CA,Oral rehydration salt formulations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA01,diphenoxylate,15,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA02,opium,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA03,loperamide,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA04,difenoxin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA05,loperamide oxide,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA06,eluxadoline,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA52,"morphine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,The DDDs are based on treatment of acute diarrhea.,A07DA53,"loperamide, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA01,prednisolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA02,hydrocortisone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA03,prednisone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA04,betamethasone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA05,tixocortol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA06,budesonide,9,NA,NA,1.5,NA,NA,mg,NA,NA,mg,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,The DDDs are given as 1 enema.  The DDD for hydrocortisone rectal foam is given in amount of active substance.The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.,A07EA07,beclometasone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EB,"Antiallergic agents, excl. corticosteroids",The DDD is based on treatment of food allergy.,A07EB01,cromoglicic acid,0.8,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,The DDDs are based on treatment of colitis ulcerosa and morbus Crohn.,A07EC01,sulfasalazine,2,NA,2,NA,NA,NA,g,NA,g,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,The DDDs are based on treatment of colitis ulcerosa and morbus Crohn.,A07EC02,mesalazine,1.5,NA,1.5,NA,NA,NA,g,NA,g,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,The DDDs are based on treatment of colitis ulcerosa and morbus Crohn.,A07EC03,olsalazine,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,The DDDs are based on treatment of colitis ulcerosa and morbus Crohn.,A07EC04,balsalazide,6.75,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07F,ANTIDIARRHEAL MICROORGANISMS,A07FA,Antidiarrheal microorganisms,The DDDs are given in UDs (e.g. numbers of tablets).,A07FA01,lactic acid producing organisms,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07F,ANTIDIARRHEAL MICROORGANISMS,A07FA,Antidiarrheal microorganisms,The DDDs are given in UDs (e.g. numbers of tablets).,A07FA02,saccharomyces boulardii,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07F,ANTIDIARRHEAL MICROORGANISMS,A07FA,Antidiarrheal microorganisms,The DDDs are given in UDs (e.g. numbers of tablets).,A07FA03,escherichia coli,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07F,ANTIDIARRHEAL MICROORGANISMS,A07FA,Antidiarrheal microorganisms,The DDDs are given in UDs (e.g. numbers of tablets).,A07FA51,"lactic acid producing organisms, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA01,albumin tannate,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA02,ceratonia,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA03,calcium compounds,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA04,racecadotril,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA06,crofelemer,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS,A07XA,Other antidiarrheals,NA,A07XA51,"albumin tannate, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA01,phentermine,15,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA02,fenfluramine,0.12,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA03,amfepramone,75,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA04,dexfenfluramine,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA05,mazindol,1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA06,etilamfetamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA07,cathine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA08,clobenzorex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA09,mefenorex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA10,sibutramine,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA11,lorcaserin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA12,setmelanotide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA51,phentermine and topiramate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA56,"ephedrine, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,NA,A08AA62,bupropion and naltrexone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AB,Peripherally acting antiobesity products,NA,A08AB01,orlistat,0.36,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AX,Other antiobesity drugs,NA,A08AX01,rimonabant,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,Enzyme preparations,"DDDs can be difficult to establish because of great variations in enzyme content.  The DDDs are based on average recommended doses given in different drug catalogues.  Most of the preparations are combinations of different enzymes, and the DDDs are therefore given in UDs.  Some specific products have been given a DDD, see list of DDDs for combination products, www.whocc.no.",A09AA01,diastase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,Enzyme preparations,"DDDs can be difficult to establish because of great variations in enzyme content.  The DDDs are based on average recommended doses given in different drug catalogues.  Most of the preparations are combinations of different enzymes, and the DDDs are therefore given in UDs.  Some specific products have been given a DDD, see list of DDDs for combination products, www.whocc.no.",A09AA02,"multienzymes (lipase, protease etc.)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,Enzyme preparations,"DDDs can be difficult to establish because of great variations in enzyme content.  The DDDs are based on average recommended doses given in different drug catalogues.  Most of the preparations are combinations of different enzymes, and the DDDs are therefore given in UDs.  Some specific products have been given a DDD, see list of DDDs for combination products, www.whocc.no.",A09AA03,pepsin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,Enzyme preparations,"DDDs can be difficult to establish because of great variations in enzyme content.  The DDDs are based on average recommended doses given in different drug catalogues.  Most of the preparations are combinations of different enzymes, and the DDDs are therefore given in UDs.  Some specific products have been given a DDD, see list of DDDs for combination products, www.whocc.no.",A09AA04,tilactase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,Acid preparations,NA,A09AB01,glutamic acid hydrochloride,1.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,Acid preparations,NA,A09AB02,betaine hydrochloride,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,Acid preparations,NA,A09AB03,hydrochloric acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,Acid preparations,NA,A09AB04,citric acid,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AC,"Enzyme and acid preparations, combinations",NA,A09AC01,pepsin and acid preparations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AC,"Enzyme and acid preparations, combinations",NA,A09AC02,multienzymes and acid preparations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB01,insulin (human),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB02,insulin (beef),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB03,insulin (pork),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB04,insulin lispro,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB05,insulin aspart,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB06,insulin glulisine,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",The DDD for insulins is 40 units.,A10AB30,combinations,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",The DDD for insulins is 40 units.,A10AC01,insulin (human),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",The DDD for insulins is 40 units.,A10AC02,insulin (beef),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",The DDD for insulins is 40 units.,A10AC03,insulin (pork),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",The DDD for insulins is 40 units.,A10AC04,insulin lispro,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",The DDD for insulins is 40 units.,A10AC30,combinations,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD01,insulin (human),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD02,insulin (beef),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD03,insulin (pork),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD04,insulin lispro,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD05,insulin aspart,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD06,insulin degludec and insulin aspart,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",The DDD for insulins is 40 units.,A10AD30,combinations,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE01,insulin (human),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE02,insulin (beef),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE03,insulin (pork),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE04,insulin glargine,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE05,insulin detemir,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE06,insulin degludec,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE07,insulin icodec,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE30,combinations,NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE54,insulin glargine and lixisenatide,NA,40,NA,NA,NA,Refers to insulin glargine,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",The DDD for insulins is 40 units.,A10AE56,insulin degludec and liraglutide,NA,40,NA,NA,NA,Refers to insulin degludec,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AF,Insulins and analogues for inhalation,The DDD for insulins is 40 units.,A10AF01,insulin (human),NA,40,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,Biguanides,NA,A10BA01,phenformin,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,Biguanides,NA,A10BA02,metformin,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,Biguanides,NA,A10BA03,buformin,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB01,glibenclamide,7,NA,NA,NA,NA,microcryst.substance,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB01,glibenclamide,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB02,chlorpropamide,0.375,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB03,tolbutamide,1.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB04,glibornuride,38,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB05,tolazamide,0.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB06,carbutamide,0.75,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB07,glipizide,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB08,gliquidone,60,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB09,gliclazide,60,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB10,metahexamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB11,glisoxepide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB12,glimepiride,2,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas,"The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.The DDD for gliclazide is based on the modified release formulation.",A10BB31,acetohexamide,0.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BC,Sulfonamides (heterocyclic),NA,A10BC01,glymidine,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD01,phenformin and sulfonylureas,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD02,metformin and sulfonylureas,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD03,metformin and rosiglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD04,glimepiride and rosiglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD05,metformin and pioglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD06,glimepiride and pioglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD07,metformin and sitagliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD08,metformin and vildagliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD09,pioglitazone and alogliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD10,metformin and saxagliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD11,metformin and linagliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD12,pioglitazone and sitagliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD13,metformin and alogliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD14,metformin and repaglinide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD15,metformin and dapagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD16,metformin and canagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD17,metformin and acarbose,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD18,metformin and gemigliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD19,linagliptin and empagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD20,metformin and empagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD21,saxagliptin and dapagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD22,metformin and evogliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD23,metformin and ertugliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD24,sitagliptin and ertugliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD25,"metformin, saxagliptin and dapagliflozin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD26,metformin and lobeglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD27,"metformin, linagliptin and empagliflozin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD28,metformin and teneligliptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BD,Combinations of oral blood glucose lowering drugs,"It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components.  One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily.  The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.See list of DDDs for combined products, www.whocc.no.",A10BD29,sitagliptin and dapagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BF,Alpha glucosidase inhibitors,NA,A10BF01,acarbose,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BF,Alpha glucosidase inhibitors,NA,A10BF02,miglitol,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BF,Alpha glucosidase inhibitors,NA,A10BF03,voglibose,0.6,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,Thiazolidinediones,The DDD for troglitazone is based on combination therapy.  The DDDs for rosiglitazone and pioglitazone are based on monotherapy.,A10BG01,troglitazone,0.4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,Thiazolidinediones,The DDD for troglitazone is based on combination therapy.  The DDDs for rosiglitazone and pioglitazone are based on monotherapy.,A10BG02,rosiglitazone,6,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,Thiazolidinediones,The DDD for troglitazone is based on combination therapy.  The DDDs for rosiglitazone and pioglitazone are based on monotherapy.,A10BG03,pioglitazone,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,Thiazolidinediones,The DDD for troglitazone is based on combination therapy.  The DDDs for rosiglitazone and pioglitazone are based on monotherapy.,A10BG04,lobeglitazone,0.5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH01,sitagliptin,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH02,vildagliptin,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH03,saxagliptin,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH04,alogliptin,25,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH05,linagliptin,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH06,gemigliptin,50,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH07,evogliptin,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH08,teneligliptin,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH51,sitagliptin and simvastatin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,A10BH52,gemigliptin and rosuvastatin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ01,exenatide,NA,0.286,NA,NA,NA,depot inj,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ01,exenatide,NA,15,NA,NA,NA,NA,NA,mcg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ02,liraglutide,NA,1.5,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ03,lixisenatide,NA,20,NA,NA,NA,NA,NA,mcg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ04,albiglutide,NA,5.7,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ05,dulaglutide,NA,0.16,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ06,semaglutide,10.5,0.11,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,A10BJ07,beinaglutide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK01,dapagliflozin,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK02,canagliflozin,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK03,empagliflozin,17.5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK04,ertugliflozin,10,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK05,ipragliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK06,sotagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK07,luseogliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,A10BK08,bexagliflozin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX01,guar gum,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX02,repaglinide,4,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX03,nateglinide,0.36,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX05,pramlintide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX06,benfluorex,0.45,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX08,mitiglinide,30,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX15,imeglimin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX16,tirzepatide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX17,carfloglitazar,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,A10BX18,dorzagliatin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10X,OTHER DRUGS USED IN DIABETES,A10XA,Aldose reductase inhibitors,NA,A10XA01,tolrestat,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A10,DRUGS USED IN DIABETES,A10X,OTHER DRUGS USED IN DIABETES,A10XX,Other drugs used in diabetes,NA,A10XX01,teplizumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11A,"MULTIVITAMINS, COMBINATIONS",A11AA,Multivitamins with minerals,"The DDDs are based on prophylaxis.  For simplicity, the DDDs for oral formulations are given as fixed doses (1 tablet = 1 UD; 30 ml mixture = 6 UD).",A11AA01,multivitamins and iron,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11A,"MULTIVITAMINS, COMBINATIONS",A11AA,Multivitamins with minerals,"The DDDs are based on prophylaxis.  For simplicity, the DDDs for oral formulations are given as fixed doses (1 tablet = 1 UD; 30 ml mixture = 6 UD).",A11AA02,multivitamins and calcium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11A,"MULTIVITAMINS, COMBINATIONS",A11AA,Multivitamins with minerals,"The DDDs are based on prophylaxis.  For simplicity, the DDDs for oral formulations are given as fixed doses (1 tablet = 1 UD; 30 ml mixture = 6 UD).",A11AA03,"multivitamins and other minerals, incl. combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11A,"MULTIVITAMINS, COMBINATIONS",A11AA,Multivitamins with minerals,"The DDDs are based on prophylaxis.  For simplicity, the DDDs for oral formulations are given as fixed doses (1 tablet = 1 UD; 30 ml mixture = 6 UD).",A11AA04,multivitamins and trace elements,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11A,"MULTIVITAMINS, COMBINATIONS",A11AB,"Multivitamins, other combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11B,"MULTIVITAMINS, PLAIN",A11BA,"Multivitamins, plain",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CA,"Vitamin A, plain",The DDD is based on treatment of vitamin A deficiency.,A11CA01,retinol (vit A),50,50,NA,NA,NA,NA,TU,TU,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CA,"Vitamin A, plain",The DDD is based on treatment of vitamin A deficiency.,A11CA02,betacarotene,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CB,Vitamin A and D in combination,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC01,ergocalciferol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC02,dihydrotachysterol,1,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC03,alfacalcidol,1,1,NA,NA,NA,NA,mcg,mcg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC04,calcitriol,1,1,NA,NA,NA,NA,mcg,mcg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC05,colecalciferol,20,NA,NA,NA,NA,NA,mcg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC06,calcifediol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,The DDDs are based on therapeutic use.  No DDD is established for ergocalciferol due to great differences between doses used for various indications. The DDD of 20 mcg colecalciferol corresponds to 800 IU.,A11CC55,"colecalciferol, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DA,"Vitamin B1, plain",The DDDs are based on treatment of vitamin B1 deficiency.,A11DA01,thiamine (vit B1),50,50,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DA,"Vitamin B1, plain",The DDDs are based on treatment of vitamin B1 deficiency.,A11DA02,sulbutiamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DA,"Vitamin B1, plain",The DDDs are based on treatment of vitamin B1 deficiency.,A11DA03,benfotiamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DB,Vitamin B1 in combination with vitamin B6 and/or vitamin B12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",A11EA,"Vitamin B-complex, plain",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",A11EB,Vitamin B-complex with vitamin C,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",A11EC,Vitamin B-complex with minerals,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",A11ED,Vitamin B-complex with anabolic steroids,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",A11EX,"Vitamin B-complex, other combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11G,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",A11GA,"Ascorbic acid (vitamin C), plain","The DDD refers to the assumed daily requirement.For combination products, the DDDs are given as fixed doses for all tablets (1 tablet = 1 UD).",A11GA01,ascorbic acid (vit C),0.2,0.2,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11G,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",A11GB,"Ascorbic acid (vitamin C), combinations","The DDD refers to the assumed daily requirement.For combination products, the DDDs are given as fixed doses for all tablets (1 tablet = 1 UD).",A11GB01,ascorbic acid (vit C) and calcium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA01,nicotinamide,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA02,pyridoxine (vit B6),0.16,0.16,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA03,tocopherol (vit E),0.2,0.2,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA04,riboflavin (vit B2),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA05,biotin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA06,pyridoxal phosphate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA07,inositol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA08,tocofersolan,0.2,NA,NA,NA,NA,Expressed as tocopherol,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA30,dexpanthenol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA31,calcium pantothenate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS,A11HA,Other plain vitamin preparations,"DDDs are established only for tocopherol, pyridoxine and nicotinamide, and refer to assumed daily requirement in vitamin deficiency.",A11HA32,pantethine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11J,"OTHER VITAMIN PRODUCTS, COMBINATIONS",A11JA,Combinations of vitamins,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11J,"OTHER VITAMIN PRODUCTS, COMBINATIONS",A11JB,Vitamins with minerals,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A11,VITAMINS,A11J,"OTHER VITAMIN PRODUCTS, COMBINATIONS",A11JC,"Vitamins, other combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA01,calcium phosphate,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA02,calcium glubionate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA03,calcium gluconate,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA04,calcium carbonate,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA05,calcium lactate,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA06,calcium lactate gluconate,3,NA,NA,NA,NA,equivalent to 0.5 g Ca2+,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA07,calcium chloride,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA08,calcium glycerylphosphate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA09,calcium citrate lysine complex,0.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA10,calcium glucoheptonate,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA11,calcium pangamate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA13,calcium citrate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA20,calcium (different salts in combination),0.5,NA,NA,NA,NA,Ca2+,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AA,Calcium,The DDDs are based on treatment of calcium deficiency and osteoporosis.,A12AA30,calcium laevulate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM,A12AX,"Calcium, combinations with vitamin D and/or other drugs",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA01,potassium chloride,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA02,potassium citrate,4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA03,potassium hydrogentartrate,7.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA04,potassium hydrogencarbonate,4,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA05,potassium gluconate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA30,potassium (different salts in combination),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM,A12BA,Potassium,The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.,A12BA51,"potassium chloride, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CA,Sodium,The DDD has been set to 1 g NaCl.,A12CA01,sodium chloride,1,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CA,Sodium,The DDD has been set to 1 g NaCl.,A12CA02,sodium sulfate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CB,Zinc,The DDD is based on treatment of zinc deficiency.,A12CB01,zinc sulfate,0.6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CB,Zinc,The DDD is based on treatment of zinc deficiency.,A12CB02,zinc gluconate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CB,Zinc,The DDD is based on treatment of zinc deficiency.,A12CB03,zinc protein complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC01,magnesium chloride,2.5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC02,magnesium sulfate,3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC03,magnesium gluconate,5,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC04,magnesium citrate,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC05,magnesium aspartate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC06,magnesium lactate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC07,magnesium levulinate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC08,magnesium pidolate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC09,magnesium orotate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC10,magnesium oxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CC,Magnesium,The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose).  -,A12CC30,magnesium (different salts in combination),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CD,Fluoride,The DDD is based on treatment of osteoporosis.,A12CD01,sodium fluoride,88,NA,NA,NA,NA,40 mg fluoride,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CD,Fluoride,The DDD is based on treatment of osteoporosis.,A12CD02,sodium monofluorophosphate,0.152,NA,NA,NA,NA,20 mg fluoride,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CD,Fluoride,The DDD is based on treatment of osteoporosis.,A12CD51,"fluoride, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CE,Selenium,The DDDs are based on treatment of selenium deficiency and is expressed as amount of selenium (Se).,A12CE01,sodium selenate,0.2,NA,NA,NA,NA,Se,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CE,Selenium,The DDDs are based on treatment of selenium deficiency and is expressed as amount of selenium (Se).,A12CE02,sodium selenite,0.2,NA,NA,NA,NA,Se,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS,A12CX,Other mineral products,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A13,TONICS,A13A,TONICS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA01,androstanolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA02,stanozolol,5,3.5,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA03,metandienone,5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA04,metenolone,10,7,NA,NA,NA,NA,mg,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA05,oxymetholone,0.25,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA06,quinbolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA07,prasterone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA08,oxandrolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,The DDDs are based on e.g. treatment of anemia.,A14AA09,norethandrolone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AB,Estren derivatives,The DDDs are based on e.g. treatment of anemia.,A14AB01,nandrolone,NA,2,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AB,Estren derivatives,The DDDs are based on e.g. treatment of anemia.,A14AB02,ethylestrenol,2,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AB,Estren derivatives,The DDDs are based on e.g. treatment of anemia.,A14AB03,oxabolone cipionate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14B,OTHER ANABOLIC AGENTS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA01,levocarnitine,2,2,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA02,ademetionine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA03,glutamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA04,mercaptamine,2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA05,carglumic acid,0.2,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA06,betaine,6,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AA,Amino acids and derivatives,The DDD of levocarnitine is based on treatment of primary carnitine deficiency.,A16AA07,metreleptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB01,alglucerase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB02,imiglucerase,NA,300,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB03,agalsidase alfa,NA,1,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB04,agalsidase beta,NA,5,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB05,laronidase,NA,1,NA,NA,NA,NA,NA,TU,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB06,sacrosidase,68,NA,NA,NA,NA,NA,TU,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB07,alglucosidase alfa,NA,0.1,NA,NA,NA,NA,NA,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB08,galsulfase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB09,idursulfase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB10,velaglucerase alfa,NA,300,NA,NA,NA,NA,NA,U,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB11,taliglucerase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB12,elosulfase alfa,NA,20,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB13,asfotase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB14,sebelipase alfa,NA,5,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB15,velmanase alfa,NA,10,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB16,idursulfase beta,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB17,cerliponase alfa,NA,21,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB18,vestronidase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB19,pegvaliase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB20,pegunigalsidase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB21,atidarsagene autotemcel,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB22,avalglucosidase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB23,cipaglucosidase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB24,pegzilarginase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB25,olipudase alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB26,eladocagene exuparvovec,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AB,Enzymes,NA,A16AB27,pabinafusp alfa,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX01,thioctic acid,0.6,0.6,NA,NA,NA,NA,g,g,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX02,anethole trithione,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX03,sodium phenylbutyrate,20,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX04,nitisinone,20,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX05,zinc acetate,0.15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX06,miglustat,0.3,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX07,sapropterin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX08,teduglutide,NA,5,NA,NA,NA,NA,NA,mg,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX09,glycerol phenylbutyrate,15,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX10,eliglustat,0.168,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX11,sodium benzoate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX12,trientine,0.45,NA,NA,NA,NA,Expressed as trientine,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX13,uridine triacetate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX14,migalastat,61.5,NA,NA,NA,NA,NA,mg,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX15,telotristat,0.75,NA,NA,NA,NA,NA,g,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX16,givosiran,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX17,triheptanoin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX18,lumasiran,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX19,fosdenopterin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX20,lonafarnib,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX21,elivaldogene autotemcel,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX22,tiomolibdic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX23,leriglitazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
A,ALIMENTARY TRACT AND METABOLISM,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,A16AX,Various alimentary tract and metabolism products,The DDD for zinc acetate is expressed as the amount of zinc (Zn).The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg.The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy.The DDD for miglustat is based on the treatment of Gauchers disease.,A16AX30,sodium benzoate and sodium phenylacetate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
